Jakarta –
Denza, BYDS premium sub-brand, has rapidly gained traction in Indonesia, achieving critically important sales figures within its first seven months of operation. The Denza D9, the brand’s sole offering in the Indonesian market, is challenging established players in the luxury MPV segment.
Denza entered the Indonesian market targeting affluent consumers seeking a premium Multi Purpose Vehicle (MPV), directly competing with models like the Toyota Alphard, Toyota Vellfire, and lexus LM350.
SCROLL TO CONTINUE WITH CONTENT
The introduction of Denza aims to attract consumers to the premium electric MPV market.
The Denza D9 was launched on January 22, 2025, with a price of Rp. 950 million (on-the-road Jakarta). This pricing strategy, coupled with comprehensive after-sales support, is a key component of Denza’s market entry.
Denza provides a 6-year/150,000 km vehicle warranty, an 8-year/150,000 km motor warranty, and an 8-year/160,000 km battery warranty, demonstrating confidence in its product and commitment to customer satisfaction.
Sales data indicates the Denza D9 is a major contributor to BYD’s overall sales performance in Indonesia. Since its launch, over five thousand luxury electric MPVs have been delivered to customers.
According to wholesale data from the Association of Indonesian Automotive Industries (Gaikindo), Denza distributed 6,256 units to dealerships. This performance places Denza as the 13th best-selling car brand in Indonesia.
Retail sales figures show 5,516 Denza D9 units were delivered to consumers, securing the brand the 11th position in the best-selling car brand rankings, trailing Wuling’s 10,971 units. March saw the highest retail sales with 1,801 units, followed by June with 1,128 units.
BYD currently operates five dedicated Denza dealerships in major Indonesian cities, including Jakarta, Surabaya, and Medan. Plans are underway to expand this network with the addition of five more dealerships in the near future, aiming to enhance accessibility and customer service.
Watch Live DetikPagi:
(Riar/din)
Google Boosts AI Mode with Advanced Gemini Features
Search Chatbot Gains Deeper Understanding and Business Calling Capabilities
Google is significantly enhancing its AI-powered Search chatbot, now called AI Mode, by integrating the powerful Gemini 2.5 Pro model and a new “Deep Search” functionality. This move signals Google’s strategic push to make AI Mode the central hub for interacting with its core search engine.
Enhanced AI Capabilities Unveiled
Subscribers to Google AI Pro and Google AI Ultra will gain access to these upgraded tools. While Gemini 2.5 Pro and Deep Search have previously been available independently, their inclusion within AI Mode indicates a consolidation of Google’s AI strategy.
AI Takes on Business Inquiries
A notable new feature allows Gemini to initiate phone calls to local businesses on behalf of users. Initially, this capability will be limited to inquiries about product availability and pricing. Users searching for businesses or services may encounter an option like “Have AI check prices,” which will trigger an automated call.
This AI-driven business communication is rolling out to all Search users today. Google AI Pro and AI Ultra subscribers will benefit from expanded usage limits for these automated calls.
Future of Search Driven by AI
These updates follow announcements made at Google’s I/O conference. AI Mode began its widespread rollout in May, alongside the introduction of Deep Think, a reasoning model for Gemini 2.5 Pro. The integration of these advanced AI tools into the familiar Search interface aims to streamline information discovery and user interaction.
The expanded capabilities reflect a growing trend in AI assistants moving beyond simple responses to perform more complex, real-world tasks. For instance, recent reports indicate that AI-powered customer service interactions are projected to handle 70% of all customer service queries by 2027 (Gartner, 2023).
New Zealand Cracks Down on Influencers advertising online Gambling
Table of Contents
The Department of Internal Affairs (DIA) in New Zealand is actively cracking down on influencers who promote overseas online gambling platforms, which is illegal under current regulations. The DIA has issued multiple formal warnings in March and april and continues to monitor influencer activity to ensure compliance with the law. These actions underscore the government’s commitment to regulating the online gambling landscape and protecting its citizens from potential harm.
Enforcement Actions and Penalties
The DIA has issued nine warning letters and is monitoring 27 influencers. Advertising overseas gambling in New Zealand carries a maximum fine of NZ,000. The DIA has not disclosed the names of those who received warnings or are under surveillance. The crackdown highlights the seriousness with which the Department views illegal gambling advertising and its willingness to take regulatory action.
Did You Know? New Zealand’s Gambling Act 2003 prohibits advertising of overseas gambling operators within the country.
Proposed Regulatory Changes
Act deputy leader Brooke van Velden has introduced the Online Gambling Bill to regulate online gambling in New Zealand. The bill proposes fines of up to $5 million for unlicensed operators. The government plans to auction 15 online casino licenses, expected to generate up to $200 million in revenue. Licenses would be issued for three years starting in Febuary 2026 under the new regime.
These changes aim to create a regulated online gambling market, providing a safer environment for consumers and generating revenue for the government. According to a 2023 report by the Problem Gambling Foundation of New Zealand, online gambling is associated with higher rates of problem gambling compared to traditional forms of gambling.
Influencer Response and Ethical Considerations
Some influencers have rejected approaches from offshore gambling sites, demonstrating a growing awareness of ethical considerations and regulatory risks. One influencer, identified as Elder-holmes, responded to a complaint by stating that she is paid to promote various products and runs her Instagram account as a business. She asserted her right to engage in adult activities as an adult.
Pro Tip: Influencers should consult with legal counsel to ensure compliance with advertising regulations and ethical guidelines.
Key Statistics and Timelines
| Metric | Value |
|---|---|
| maximum Fine for Advertising overseas Gambling | NZ$10,000 |
| Proposed Fine for Unlicensed Operators (Online Gambling Bill) | up to $5 Million |
| Number of Warning Letters Issued by DIA | 9 |
| Number of Influencers Being Monitored by DIA | 27 |
| expected Revenue from Online Casino Licenses | Up to $200 Million |
| Online Casino Licenses Issuance Date | February 2026 |
Resources for Problem Gambling
For those struggling with gambling-related issues, several resources are available:
- The Gambling Helpline: 0800 654 655 (available 7 days a week, also by texting 8006)
- Māori Gambling Helpline: 0800 654 656
- vai Lelei Pasifika Gambling Helpline: 0800 654 657
- Youth Gambling Helpline “In Ya Face”: 0800 654 659
- Gambling Debt Helpline: 0800 654 658
These helplines provide confidential support and guidance for individuals and families affected by problem gambling. According to the Ministry of Health, approximately 1% of New Zealand adults experience problem gambling, with an additional 2-4% experiencing moderate-risk gambling.
The Evolution of gambling Regulations in New Zealand
New Zealand’s approach to gambling regulation has evolved considerably over the past few decades. Historically, gambling was primarily land-based, with casinos and lotteries being the main forms. However, the advent of the internet brought about new challenges, as offshore online gambling platforms became increasingly accessible to New Zealand residents. This lead to concerns about consumer protection, problem gambling, and the potential for revenue loss to overseas operators.
The Gambling Act 2003 was a landmark piece of legislation that aimed to regulate the gambling industry in New Zealand. However, it did not fully address the complexities of online gambling, particularly the activities of offshore operators. The proposed Online Gambling Bill represents a important step towards modernizing the regulatory framework and addressing the challenges posed by the digital age.
frequently Asked Questions About Online Gambling Regulations in New Zealand
Disclaimer: This article provides general information and should not be considered legal or financial advice. Consult with a professional for specific guidance.
What are your thoughts on the proposed online gambling regulations? Do you think they go far enough to protect consumers?
Share this article and join the conversation!
Formosa Nuclear Medicine Center‘s Advanced Mammography Wins International Award
Table of Contents
The Nuclear Medicine and Radiation Center for Formosa, Argentina, has been awarded second prize in the Mample Images category at the XIII SIBIM Congress 2025, held in Rosario. The award recognizes the center’s innovative local method utilizing mammography studies with contrast.
Recognition at XIII SIBIM Congress 2025
The center’s presentation stood out among more than 60 scientific presentations from across Argentina and abroad. The distinction highlights Formosa’s commitment to advancing medical imaging and improving breast cancer detection.
Did You Know? Contrast-enhanced mammography can improve the accuracy of breast cancer screening, especially in women with dense breast tissue.
Innovative Mammography with Contrast
Dr. maría Paula Antueno, who led the diagnostic and breast intervention team, emphasized the significance of the award. She stated that it “manages to position Formosa in a prominent place within the medical field,reflecting the commitment and professionalism of a whole work team.”
The center’s work, titled “Mammography with contrast in Formosa: initial experience,” showcases the use of advanced technology, including a mammographer with contrast installed in the Cemenurnk. This technology allows women in Formosa access to precise diagnoses without traveling long distances to larger medical centers.
Benefits of Advanced Technology
According to Dr. Antueno, this technology significantly improves breast cancer detection, is fast and accessible, and frequently enough eliminates the need for additional complementary studies. Mammograms are considered the best way to find breast cancer early, increasing the chances of successful treatment [1].
pro tip: Regular mammograms can lower the risk of dying from breast cancer, especially for women aged 40 to 74 [3].
Impact on Breast Cancer Detection
Breast cancer remains a leading cause of cancer deaths among women worldwide, making early detection crucial for improved prognosis and survival [2]. The Formosa Nuclear Medicine Center’s innovative approach contributes significantly to this effort within Northern Argentina.
| Metric | Details |
|---|---|
| Award | Second Prize, Mample Images Category |
| Congress | XIII SIBIM Congress 2025 |
| Location | Rosario, Argentina |
| Technology | Mammography with Contrast |
| Benefit | Improved Breast Cancer Detection |
Evergreen Insights: The Importance of Mammography
Mammography has been a cornerstone of breast cancer screening for decades. It allows for the detection of tumors before they are palpable, significantly increasing the chances of successful treatment.Ongoing advancements in mammography technology, such as digital breast tomosynthesis (DBT) and contrast-enhanced mammography, continue to improve the accuracy and effectiveness of screening programs.
Frequently Asked Questions About Mammography
Why is early detection of breast cancer so important?
Early detection allows for less aggressive treatment options and significantly improves the chances of survival.
How often should women undergo mammography screening?
Screening guidelines vary, but annual or biennial mammograms are generally recommended for women starting at age 40.Consult with yoru healthcare provider to determine the best screening schedule for you.
What are the limitations of mammography?
Mammography may not detect all cancers, particularly in women with dense breast tissue. Additional imaging modalities, such as ultrasound or MRI, might potentially be recommended in certain cases.
what are your thoughts on the importance of accessible, advanced medical technology in rural areas? Share your experiences and opinions in the comments below!
Enjoyed this article? Share it with your friends and family to spread awareness about the latest advancements in breast cancer detection!
Dyne Therapeutics to Present DYNE-101 Update for myotonic Dystrophy Type 1
Table of Contents
WALTHAM, Mass. – June 16, 2025 – dyne Therapeutics, Inc.(Nasdaq: DYN), a company focused on developing therapies for neuromuscular diseases, announced plans to update investors on its DYNE-101 program for myotonic dystrophy type 1 (DM1). The update will be delivered tomorrow, june 17, 2025, via a live webcast scheduled for 8:00 a.m. ET. The company plans to release a press statement before the webcast begins.
Investor Conference Call and Webcast Details
The live webcast, including an accompanying slide presentation, can be accessed on the Investors & Media section of dyne’s website under Events & Presentations. A replay of the webcast will be available for 90 days following the event. To access the live webcast and replay, visit Dyne’s Investor Relations page.
Did You No? Myotonic Dystrophy Type 1 affects approximately 1 in 8,000 people worldwide, making it one of the most common forms of muscular dystrophy in adults.
About Dyne Therapeutics
Dyne Therapeutics is dedicated to creating innovative therapies for individuals affected by genetically driven neuromuscular diseases. Utilizing its FORCE™ platform, dyne develops targeted therapeutics designed to improve delivery to muscle tissue and the central nervous system (CNS). The company’s pipeline includes clinical programs for myotonic dystrophy type 1 (DM1) and Duchenne muscular dystrophy (DMD),as well as a preclinical program for facioscapulohumeral muscular dystrophy (FSHD).
Dyne’s FORCE™ platform is engineered to overcome limitations in drug delivery, a meaningful hurdle in treating neuromuscular diseases. This innovative approach allows for more effective targeting of affected tissues, possibly leading to better patient outcomes. Recent studies highlight the importance of targeted drug delivery in treating genetic disorders.
Dyne’s Pipeline at a glance
| disease | Program | Status |
|---|---|---|
| Myotonic Dystrophy Type 1 (DM1) | DYNE-101 | Clinical |
| Duchenne Muscular Dystrophy (DMD) | [Program Name] | Clinical |
| Facioscapulohumeral Muscular Dystrophy (FSHD) | [Program Name] | Preclinical |
pro Tip: Investors often monitor webcasts and conference calls for key insights into a company’s progress and future plans.
For more information about Dyne Therapeutics, visit https://www.dyne-tx.com/. you can also follow the company on X,LinkedIn, and Facebook.
What impact could DYNE-101 have on the lives of those living with Myotonic Dystrophy Type 1?
how crucial are investor webcasts in understanding the progress of pharmaceutical companies?
Understanding Myotonic dystrophy Type 1 (DM1)
Myotonic Dystrophy Type 1 (DM1) is a multisystemic disease, meaning it affects various parts of the body, including muscles, heart, and brain. The severity and onset of symptoms can vary widely among affected individuals. The disease is caused by an expansion of a CTG repeat in the DMPK gene, leading to RNA toxicity that disrupts normal cellular function. The National Institute of Neurological Disorders and stroke (NINDS) provides complete information on DM1.
Current treatments for DM1 primarily focus on managing symptoms, as there is no cure. These treatments can include medications for myotonia, pain management, and cardiac monitoring. Research into potential disease-modifying therapies, such as DYNE-101, offers hope for improving the long-term outcomes for individuals with DM1.
Frequently Asked Questions About Dyne Therapeutics and DYNE-101
- What is the goal of Dyne Therapeutics?
- Dyne Therapeutics aims to develop therapies that can transform the lives of people living with genetically driven neuromuscular diseases.
- How does Dyne Therapeutics’ FORCE™ platform work?
- The FORCE™ platform is designed to enhance the delivery of therapeutics to muscle tissue and the central nervous system, overcoming limitations in conventional drug delivery methods.
- What are the potential benefits of DYNE-101?
- DYNE-101 is being developed to address the underlying genetic cause of Myotonic Dystrophy Type 1 (DM1),potentially slowing or halting disease progression.
- Were can I find more information about Dyne Therapeutics?
- Additional information about Dyne Therapeutics can be found on their website at https://www.dyne-tx.com/.
Disclaimer: This article provides information about Dyne Therapeutics’ planned webcast and general information about their research and growth programs. It is not intended to provide medical advice. Always consult with a qualified healthcare professional for any health concerns or before making any decisions related to your treatment or care.
Stay informed about the latest developments in neuromuscular disease research! Share this article and subscribe to our newsletter for more updates.